The risk of autoimmunity and rheumatic disease is heightened in women, especially with aging and certain populations
Distinguishing features between the 2021 ACR and 2022 EULAR RA treatment guidelines
Oral Surveillance study resulted in a new FDA drug safety bulleting 9/21/21 and since the label for all JAK inhibitors has changed (FDA, Canada) or will change (EMA).
2021-2022 New FDA Drug Approvals and New Indications
Use this resource to keep track of your clinical trials and key information needed when communicating with patients about a drug study.
What to do about information overload in medicine.
Comparison of COVID-19 deaths in the first 3 mos vs. over 30 mos since onset. USA leads the way.
An overview of how to use serologic testing - ANA, RF, CCP, ESR, CRP